Perrigo Gets "Wake-Up Call" In FDA Warning Letter
This article was originally published in The Tan Sheet
Executive Summary
Perrigo prioritized correcting manufacturing problems that drew an FDA warning, advising the firm to prevent human errors with tighter quality control, according to CEO Joseph Papa